Treatment of enteric fever--what next?
Misra
S
S
Thapa
B R
BR
Panigrahi
D
D
Mehta
S
S
D000667:Ampicillin / Q000494:pharmacology / Q000627:therapeutic use; D002439:Cefotaxime / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000494:pharmacology / Q000627:therapeutic use; D002702:Chloramphenicol Resistance / Q000502:physiology; D002939:Ciprofloxacin / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007194:India; D008297:Male; D012485:Salmonella typhi / Q000187:drug effects*; D014296:Trimethoprim Resistance / Q000502:physiology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology / Q000627:therapeutic use; D014435:Typhoid Fever / Q000188:drug therapy* / Q000382:microbiology
D002939:Ciprofloxacin; D002701:Chloramphenicol; D000667:Ampicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D002439:Cefotaxime